Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 149, 218-228
Abstract
No abstract availableKeywords
Funding Information
- Chulabhorn Research Institute
- Thailand Research Fund (IRG5980001)
- Faculty of Science, Mahidol University
This publication has 40 references indexed in Scilit:
- Antiproliferative effect of pheophorbide a–mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5Drug and Chemical Toxicology, 2013
- PLGA–LECITHIN–PEG CORE-SHELL NANOPARTICLES FOR CANCER TARGETED THERAPYNano LIFE, 2012
- Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrugPhotochemical & Photobiological Sciences, 2011
- Environment-mediated drug resistance: a major contributor to minimal residual diseaseNature Reviews Cancer, 2009
- Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitroEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer CellsPharmaceutical Research, 2006
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- A Microplate Assay for Quantitation of Anchorage-Independent Growth of Transformed CellsAnalytical Biochemistry, 1995
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI: Journal of the National Cancer Institute, 1993
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992